Merit Medical recently announced the appointment of Martha Aronson as the company’s new president and chief executive officer (CEO), effective 3 October 2025. Fred P Lampropoulos will remain as chairman of the board, president and CEO of Merit through 3 October. Upon Aronson’s appointment, Lampropoulos will continue to serve as chairman of the board.
“I am pleased to welcome Martha to Merit,” said Lampropoulos. “I believe the company has never been in a stronger position. Martha is uniquely qualified to lead Merit into the future and drive its continued success. Her keen intellect and proven track record of empowering global teams through collaborative excellence, consistent with ‘The Merit Way,’ makes her the ideal leader for Merit’s next stage of growth. Since our founding in 1987, we have achieved significant milestones, including strong returns delivered to shareholders since our IPO on 10 May 1990. I am incredibly proud of these achievements. With Martha’s experience and capability, I look forward to supporting her vision while she charts Merit’s course forward.”
Merit notes in a press release that Aronson has extensive experience in global healthcare. Her business management experience includes overseeing global healthcare businesses ranging in size from US$500 million to US$1 billion. She was the executive vice president and president of global healthcare for Ecolab and previously served as the senior vice president and president—North America for Hill-Rom Holdings. Prior to that, she spent nearly 20 years at Medtronic in various general management and leadership roles, both in the USA and internationally. Aronson guided and advised companies as a board director, most recently serving as a director, and formerly as chair of the board, for ConMed. She also served as a director of Methode Electronics, Clinical Innovations, Cardiovascular Systems, Beta Bionics, Hutchinson Technology, Bright Uro, and OmCare.
“I am excited to join Merit and truly honoured to take on this role,” said Aronson. “Fred has built and grown an extraordinary company over the past four decades, starting with one single idea and building it into the incredibly successful global company that it is today. Working with the talented team at Merit, I look forward to building upon his remarkable legacy and leading the company into a future of continued excellence and innovation.”
“The board is delighted to welcome Martha to Merit,” said F Ann Millner, lead independent director. “Through a meticulous selection process, we identified her as an exceptional fit for our organisation. With her extensive global expertise and profound understanding of our industry, we are confident she will lead Merit into a successful new chapter.”
Millner added: “On behalf of Merit’s board of directors, we extend our deepest appreciation to Fred Lampropoulos for his 38 years of leadership and dedication to Merit. Fred is a visionary leader committed to medical innovation, employee wellbeing, and community involvement. His foundation of The Merit Way will continue to inspire and guide the company for years to come. Equally admirable is Fred’s philanthropic work, reflecting his deep dedication to the wellbeing of others. As Merit’s founder, he has advanced patient care and significantly improved health outcomes worldwide. Fred’s genuine leadership reaches beyond the workplace and has touched communities around the globe.”
